Implantable Fluid Delivery System by Saab, Ihab et al.
Kettering University 
Digital Commons @ Kettering University 
Mechanical Engineering Patents Mechanical Engineering 
4-26-2018 




Lanie R. Belloli 
Massoud Tavakoli 
Kettering University, mtavakoli@kettering.edu 
Follow this and additional works at: https://digitalcommons.kettering.edu/mech_eng_patents 
 Part of the Mechanical Engineering Commons 
Recommended Citation 
Saab, Ihab; Waters, Nathan; Carne, Joel; Belloli, Lanie R.; and Tavakoli, Massoud, "Implantable Fluid 
Delivery System" (2018). Mechanical Engineering Patents. 25. 
https://digitalcommons.kettering.edu/mech_eng_patents/25 
This Patent is brought to you for free and open access by the Mechanical Engineering at Digital Commons @ 
Kettering University. It has been accepted for inclusion in Mechanical Engineering Patents by an authorized 
administrator of Digital Commons @ Kettering University. For more information, please contact 
digitalcommons@kettering.edu. 
THE TWO TORTOITUMIWUM UMUMAN 
US 20180110919A1 
( 19 ) United States 
( 12 ) Patent Application Publication ( 10 ) Pub . No . : US 2018 / 0110919 A1 
SAAB et al . ( 43 ) Pub . Date : Apr . 26 , 2018 
( 54 ) IMPLANTABLE FLUID DELIVERY SYSTEM 
( 71 ) Applicant : Ihab SAAB , Detroit , MI ( US ) 
( 72 ) Inventors : Ihab SAAB , Detroit , MI ( US ) ; Nathan 
WATERS , Negaunee , MI ( US ) ; 
Michael E . NEAL , Holly , MI ( US ) ; 
Joel CARNE , Holly , MI ( US ) ; Lanie 
R . BELLOLI , Almont , MI ( US ) ; 
Massoud S . TAVAKOLI , Flint , MI 
( US ) 
Publication Classification 
( 51 ) Int . CI . 
A61M 5 / 142 ( 2006 . 01 ) 
A61M 5 / 168 ( 2006 . 01 ) 
A61M 39 / 02 ( 2006 . 01 ) 
( 52 ) U . S . Ci . 
CPC . . . A61M 5 / 14276 ( 2013 . 01 ) ; A61M 5 / 16881 
( 2013 . 01 ) ; A61M 5 / 1723 ( 2013 . 01 ) ; A61M 
5 / 16804 ( 2013 . 01 ) ; A61M 39 / 0208 ( 2013 . 01 ) 
( 57 ) ABSTRACT ( 73 ) Assignee : Ihab SAAB , Detroit , MI ( US ) 
( 21 ) Appl . No . : 
( 22 ) PCT Filed : 
15 / 565 , 051 
Apr . 5 , 2016 
PCT / US16 / 26016 ( 86 ) PCT No . : 
$ 371 ( c ) ( 1 ) , 
( 2 ) Date : 
An implantable system for delivering fluids , such as drugs , 
to one or more anatomical structures in a patient ' s ( i . e . , 
human or animal ) body . A number of medical conditions 
require continual and / or periodic administration of fluids 
( e . g . , drugs ) to target regions ( e . g . , anatomic organs ) of the 
body . Accessibility to those target regions might be limited 
technically for ex . and not limited to : frequent endoscopic , 
radiologically guided or surgical approaches . The system 
delivers the fluid needed in a continual or intermittent 
fashion to the target region . It controls the amount of fluid 
delivered to the target region and measures the intended 
physiologic effect of the fluid delivered . 
Oct . 6 , 2017 
Related U . S . Application Data 
( 60 ) Provisional application No . 62 / 144 , 022 , filed on Apr . 
7 , 2015 . 
- - - - 34 
2 = * 
222222PPPPPPPPE 
- = = -*
= = = = = = = 
1 
- 
- - - - IT LOL TOT TTT - * — * — = — = — JUIST LIT - - - TT E - - - - - - - - - - - - - + - - til 
= = = = = - - - - i - - IL - L - - - 
- - - - - - 
- - - - SS 24 
48 
Patent Application Publication Apr . 26 , 2018 Sheet 1 of 11 US 2018 / 0110919 A1 
11 1 1 
- one on 
16b 
140 - o 
PC s? 214a ) 
AN 
FIG . 1 
Patent Application Publication Apr . 26 , 2018 Sheet 2 of 11 US 2018 / 0110919 A1 
24 97Y 80 (W\
MA FIG .2
H - ??? TI ?? - 
?? 
24 






Patent Application Publication Apr . 26 , 2018 Sheet 3 of 11 US 2018 / 0110919 A1 












EEEEE -- - - 
- 
- - - 
tit - - - - CARRERA * = E = w TSSSET L s - - - - - - - - - - - - - = = = - - T - E b = = = = = = = 11 II 1 I 1 I - 
. 
- * YLI - il * - - - - - - 2 - - - - - - - - - - - - - - - - - ESES = = = - - - 
G 
. 
FIG . 4 
- - - 34 







= = i 
- Na 
J L - 
V , IT II III LII LI TO Il NI - - IT IT ILL - - - U - FF - - - - - - - - - 4 - - - 
- - - - - - 15 + = = = = = - - - - - 4 - - 
1 
IL - L - - - - 24 48 
FIG . 5 
Patent Application Publication Apr . 26 , 2018 Sheet 4 of 11 US 2018 / 0110919 A1 
34 36 
! I IV 
11 




E - - - - - - 
- ESSEIEREAEE2238 
11 - 
- T ! 




- - T - - - - - - - th In IN 1 - - - - 11 22 * - - 11 1 11 11 111 IL - i Il + - - - VE S . . . - - il 
- 11 41 - * 11 11 11 
- 
11 11 11 - - IL Il 11 , 11 11 * 
11 111 
- Vi I TIVI 111 ! - x 28 420 42d I ill til 1111 HI 1 lll 
u 11 
- - - 
IIEEE = 4d 44a 
44c 
) 440 442 
V 
FIG . 6 
1 1 
I 
- - - 1 - 
- * Le 
II - - - - 44b40b - - - - 42a - - 11 - - * 
11 * 
1 V 1 1 
- hem III - III III III TILT III TILT TIR TILL TIL 
- - - 
= 
- - - yo k - TITIII = = = . s - - - - - - 446 - - 14 , - - 
- 
- 
- Il - - 11 - I . - - - - 11 . 44d 40d 






- - - - - 
y . - - - - - 
FIG . 7 
Patent Application Publication Apr . 26 , 2018 Sheet 5 of 11 US 2018 / 0110919 A1 
- - 








- - - - - - - - 
- 
- - - 
* 
* * 
- - - - - - - - - 



































































Apr . 26 , 2018 Sheet 6 of 11 
- - - 
- - - 
- 
FIG . 9 
to 10 
10 70 




Patent Application Publication Apr . 26 , 2018 Sheet 7 of 11 US 2018 / 0110919 A1 
74 
84 / 86 
95a 
- - - - - - - - - - - - - - F 82 - - - - - - - - 
Yr 94 
= = 0111 011 III TUO TITI 0111 IIII 1111 IIII 1111 1111 MU MI = = = = = = = VIII 
- hm MWW mr -www 
92 
88b 
= = = = = = - - - - - - - - 
Az = = = = = = = = = = = = = = = = = = = = = = 
WW - - - - - - - - - - - - - - - 
ASS = = = = = = = = L 
- - - - - - - - - - - - - - - - - - - 13223 - - 
IL 11 11 11 - 11 11 11 
_ 
- - - = = = = = = - IL 
76 68 78 160 " 30 96 
FIG . 10a 
16 - 84 / 86 
95a 95b 













MWWW .- - - - - - - = = = = = = = = = - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - HEF = = = = = = = - - - - - - - - - - - - - - - - E - - - - - - - - - - - - - - - - - - - - IN IL IL11 - - 111 - - - - - - - - - - - - - - - F = - = = 
TT 




































llllll In II = = = = = = = ; 
ill ?
III l |l |IIIIII ll IIII | I |n |il IIill IIIIII l |l II| 
Iml I ill ?
Ill IIII IIII III 
# ???????????? 
HHHHHHHHHHHHHH 























?o  . 



















FIG . 11b 

























m = = = 
Patent Application Publication 
FIN 
L? : tIIIHIE 
= * = = = = = = = = = = = = = = = = = = = = = = = = 
# # = = = = = = = = = u 
IIII III IIII IIII III III IIII IIII III 
II III I II IIII ? II| III ? III
WL??? 
- IIIIIIIII IIII III III I IIII 






FN - = - - = = = = = = = = = = = = = = = = = = HHHHH 
Ill III | Ill Ill III -
76 
92 











Patent Application Publication Apr . 26 , 2018 Sheet 9 of 11 US 2018 / 0110919 A1 
16 
82 
= = = = = ?????????? 958 ??????????? ?????? … . / 95a ?? lllllll llllll ????? 
????? ??????? ??? III Ill Ill ??????? " " ! ? ! ?" ]
h??????H? | 88a 06 
" ?" ?
di lllll-?
- ????????????????  - ??????????? ???????????????????????????? 
????????????????????? 
- - - ???? ??????????? - - - - - - - 
???????????????????????????? 
= = Y?? ??????????????????? 
* +
76 76 68 68 
FIC , 12a 
74 
~ 8486 ) 
95a95b - 82 ????????? - - , = = = = = 
= = = = = = = = = = = = = = = = Til Til ? = = = = = = = h??????? 88b lllllll llllllll ??????? lllllll ??????? - - - - - - ?????????? ???????????? ? ? ? ??? ?????????????????? : ?????????????????????????? | ???? ? - 
?????????????????? ?????????????????? 
| | 
| l | | | 






| F 88b 68 86 68 
Ill 
FIG . 125 
Patent Application Publication Apr . 26 , 2018 Sheet 10 of 11 US 2018 / 0110919 A1 




14c ???? + ?146 
? 
???? ?????????? 95a | # ??????????? ? ??? \ P104 / 105 , | 
| | 
€ c106a ?????? | | ? - - ? - - - - - 
??????? = = = = = = | 




- - ? 
- … !?? - ? - - - | ?10Ah F -T? ?? | - - - ???? ?? - - | l| - - - - -- 1 || - ? ??got S106g - - - - ?????????? 
??????????????????????????? 
???????????????????????1 
- 882 -r88a 
- - - - - - 
N |8 - - ???????? - - - - 
???????????????????????????? 
????????????????????? 
???? - - - - - ? I| | TIP ? 
76 - 7 68 10 78 108 ' 80 
? 108 
886 68 
FIG . 13 
- 16a106a 95 a " 146 - 16a 140 - 16C 144 - 16d 14a 
| 
II IT I IT I II | 
J 
88a10667 88b 88a / 106c88b 
? 106c 106b 
FIG . 14 
Patent Application Publication Apr . 26 , 2018 Sheet 11 of 11 US 2018 / 0110919 A1 
r16a 16b 
F14a ( 14b - 14c 
Er - - - - - - - - - - - - - 2???????? - - - - ????????????????? - - “ ?????? 2 
| QS90 
0 
FIG . 15 
US 2018 / 0110919 A1 Apr . 26 , 2018 
IMPLANTABLE FLUID DELIVERY SYSTEM 
[ 0001 ] This is a new international application under the 
Patent Cooperation Treaty ( PCT ) . 
TECHNICAL FIELD 
[ 0002 ] The present invention is generally related to 
implantable medical devices and , more particularly , to an 
implantable system for delivering fluids , such as drugs , to 
one or more anatomical structures in a patient ' s ( i . e . , human 
or animal ) body . 
of the fluid delivery system illustrated in FIG . 1 , with the 
needle assembly thereof in a retracted state and a deployed 
state , respectively ; 
10016 ] FIGS . 12a and 12b are diagrammatic and side 
elevation views of yet another illustrative embodiment of a 
pod of the fluid delivery system illustrated in FIG . 1 , with 
the needle assembly thereof in a retracted state and a 
deployed state , respectively ; 
[ 0017 ] FIG . 13 is a diagrammatic view showing an 
example of the fluid flow through a pod of the system 
illustrated in FIG . 1 ; 
[ 0018 ] FIG . 14 is a diagrammatic and schematic view of 
an illustrative arrangement of a plurality of pods of the 
system illustrated in FIG . 1 ; and 
100191 FIG . 15 is a diagrammatic and schematic view of 
an illustrative way of measuring the impedance of an 
anatomical structure using an arrangement of pods of the 
system illustrated in FIG . 1 . 
BACKGROUND 
[ 0003 ] A number of medical conditions require continual 
and / or periodic administration of fluids ( e . g . , drugs ) to target 
regions ( e . g . , anatomical structures ) of the body . A variety of 
implantable fluid delivery devices / systems are known and 
generally include a port having a reservoir with a catheter 
attached thereto . Fluid in the reservoir of the implanted port 
is pumped by one or more pumps through the catheter and 
to the target region ( s ) of the body . The port is implanted 
beneath the skin of the patient and may include a septum that 
is penetrable by a hypodermic needle . Thus , conventional 
injections of a medication into a patient having an implanted 
port are made by inserting a needle through the patient ' s skin 
and through the septum in the port . Fluid is injected through 
the needle and into the reservoir of the port where it passes 
into the catheter and eventually out to the target region ( s ) . 
DETAILED DESCRIPTION OF ILLUSTRATED 
EMBODIMENT ( S ) 
BRIEF DESCRIPTION OF THE DRAWINGS 
[ 0004 ] One or more embodiments of the invention will 
hereinafter be described in conjunction with the appended 
drawings , wherein like designations denote the same or 
similar elements , and wherein : 
[ 0005 ] FIG . 1 is a diagrammatic view of an illustrative 
embodiment of a fluid delivery system ; 
10006 ] FIG . 2 is an isometric view of an illustrative 
embodiment of a port of the fluid delivery system illustrated 
in FIG . 1 ; 
[ 0007 ] FIG . 3 is an isometric cross section view of the port 
illustrated in FIG . 2 , taken along the lines 3 - 3 in FIG . 2 ; 
0008 ] . FIG . 4 is an isometric view of another illustrative 
embodiment of a port of the fluid delivery system illustrated 
in FIG . 1 ; 
[ 0009 ] FIG . 5 is a side elevation view of the port illus 
trated in FIG . 4 ; 
[ 0010 ] FIG . 6 is an isometric view of a first or top portion 
of the port illustrated in FIG . 4 ; 
[ 0011 ] FIG . 7 is a top plan view of the port illustrated in 
FIG . 4 ; 
[ 0012 ] FIG . 8 is an isometric view of an illustrative 
embodiment of a bottom or base portion of the ports 
illustrated in FIGS . 2 and 4 ; 
[ 0013 ] FIG . 9 is an isometric view of a portion of an 
illustrative embodiment of a catheter of the fluid delivery 
system illustrated in FIG . 1 ; 
[ 0014 ] FIGS . 10a and 10b are diagrammatic and side 
elevation views of an illustrative embodiment of a pod of the 
fluid delivery system illustrated in FIG . 1 , with the needle 
assembly thereof in a retracted state and a deployed state , 
respectively ; 
[ 0015 ] FIGS . lla and 11b are diagrammatic and side 
elevation views of another illustrative embodiment of a pod 
[ 0020 ] The description below pertains to an implantable 
fluid delivery system that includes a port , for example , a port 
that may be implanted subcutaneously , configured to deliver 
a fluid , generally a drug , to one or more implantable pods 
located or disposed at or on one or more target anatomical 
structures ( e . g . , pylorus , bladder , etc . ) . An example of a fluid 
that may be delivered using the system and method 
described herein is botulinum toxin or botox ; though it will 
be appreciated that the system and method may be utilized 
to deliver any number of other fluids , and therefore , the 
present disclosure is not intended to be limited to the use of 
any particular fluid ( s ) . It will be further appreciated that the 
system may be used to treat any number of diseases or 
conditions in which fluid has to be delivered ( e . g . , injected 
into ) one or more anatomical structures and / or one or more 
locations or regions of an anatomical structure . These dis 
eases / conditions may include , but are certainly not limited 
to , bladder and urethral dysfunction , overactive bladder 
syndrome , benign prostatic hyperplasia , painful bladder 
syndrome / interstitial cystitis , achalasia , and obesity to cite 
only a few possibilities . Accordingly , it will be appreciated 
that use of the system described herein is not intended to be 
limited to the treatment of any particular disease ( s ) / condi 
tion ( s ) , and / or to the implantation of the devices of the 
system at any particular location ( s ) within a patient ' s 
anatomy . 
[ 0021 ] With reference to FIG . 1 , there is shown a dia 
grammatic representation of a fluid delivery system 10 
implanted within the body of a patient , in this case , the body 
of a human being . According to an embodiment , the fluid 
delivery system 10 ( hereinafter “ system 10 " ) generally 
includes a port 12 , one or more catheters 14 , and one or more 
implantable pods 16 . As will be described in greater detail 
below , at least one of the catheters 14 ( catheter 14a in FIG . 
1 ) is configured to couple ( e . g . , fluidly , electrically , etc . ) the 
port 12 to at least one of the pods 16 ( pod 16a in FIG . 1 ) , 
while one or more other of the catheters 14 ( if applicable ) 
are configured to couple two adjacent pods 16 together and 
to facilitate fluid communication and , in at least some 
embodiments , electrical connection / communication , ther 
ebetween ( e . g . , catheter 14b couples pod 16a to pod 16b , and 
catheter 14c couples pod 16b to pod 160 ) . In at least some 
embodiments , the system 10 may include additional com 
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ponents , for example and without limitation , an interrogator 
18 or other base station configured to communicate with 
electronics housed within the port 12 and / or pod ( s ) 16 . In 
other embodiments , however , that or those additional com 
ponents may be separate and distinct from the system 10 but 
may be used in conjunction therewith . 
[ 0022 ] In an embodiment , the port 12 may be an implant 
able port configured to be implanted underneath the surface 
of the skin and to be held in place by , for example , suturing 
the port 12 to a muscle wall or another anatomical structure 
beneath the surface of the skin . As illustrated in , for 
example , FIGS . 2 and 4 , the port 12 generally comprises a 
body 20 that , in an embodiment , includes a first portion 22 
and a second portion 24 , and includes or defines a central 
axis A . The first and second portions 22 , 24 may be 
integrally formed so as to form a single piece , or , alterna 
tively , may comprise separate pieces that are operatively 
coupled together ( i . e . , directly coupled or indirectly coupled 
via intervening component ( s ) using techniques well - known 
in the art ( e . g . , friction or interference fit connections , 
threaded connections , mechanical fasteners , and / or adhe 
sives , to cite just a few possibilities ) . 
[ 0023 ] In an embodiment , the first portion 22 of the port 
12 has a first end 26 and a second end 28 opposite the first 
end 26 . The first portion 22 further includes an opening 30 
at a first end 26 providing access to a fluid reservoir 32 
disposed within the first portion 22 . In an embodiment , the 
port 12 includes a diaphragm or septum 34 that is carried by 
the body 20 ( e . g . , the first portion 22 of the body 20 ) and that 
extends across and overlays the opening 30 . The septum 34 
is penetrable by a needle of or carried by a syringe to fill the 
reservoir 32 with fluid that is to be delivered to the pod ( s ) 16 . 
In an embodiment , the septum 34 may comprise a silicon 
membrane ; though in other embodiments the septum 34 may 
take other forms . The septum 34 may be coupled to the first 
port 22 in a number of ways . One way comprises affixing the 
septum 34 to an affixation surface ( not shown ) , which may 
be an axially - facing surface that faces away from the body 
20 of the port 12 , using a suitable adhesive . In another 
embodiment , the septum 34 may be coupled to the port as 
part of the molding process used to form or construct the 
port 12 . In such embodiment , both the periphery of the 
septum 24 and the affixation surface may be encapsulated in 
the port 12 during the port manufacturing process . It will be 
appreciated , however , that other suitable coupling tech 
niques may additionally or alternatively be utilized . 
[ 0024 ] In an embodiment , the reservoir 32 extends from 
the opening 30 at the first end 26 of the first portion 22 to an 
intermediate point between the first and second ends 26 , 28 
of the first portion 22 , and may be defined or bounded by one 
or more walls . For example , in the embodiment illustrated in 
FIGS . 2 and 3 , the reservoir 32 may include one or more side 
walls 36 extending axially from the opening 30 ( or in close 
proximity thereto ) to a bottom wall 38 . In another embodi 
ment , such as , for example , that illustrated in FIG . 4 , the 
reservoir 32 may have a substantially funnel or conical 
shape having one or more side walls 36 extending both 
axially and radially - inward from the opening 30 to a point or 
bottom wall located between the first and second ends 26 , 28 
of the first portion 22 . Accordingly , it will be appreciated 
that the reservoir 32 is not limited to any particular con 
figuration ( s ) , but rather any suitable configuration may be 
utilized . 
( 0025 ] The port 12 may include one or more fluid pas 
sageways 40 in fluid communication with the reservoir to 
allow fluid to flow out of the reservoir 32 . The passageway 
( s ) 40 may extend from the bottom of the reservoir 32 ( e . g . , 
from a bottom wall of the reservoir 32 ( as shown in FIG . 3 ) ) 
or from a sidewall ( as shown in , for example , FIGS . 6 and 
7 ) , though other configurations and arrangements are cer 
tainly possible . In an embodiment such as that illustrated in 
FIGS . 2 and 3 , the passageways ( s ) 40 fluidly couple the 
reservoir 32 to the catheter 14 that , in turn , couples the port 
12 with one or more of the pods 16 . 
100261 In other embodiments such as , for example , that 
illustrated in FIGS . 4 - 7 , the passageway ( s ) 40 fluidly couple 
the reservoir 32 to one or more chambers 42 ( e . g . , a plurality 
of chambers ) disposed in the first portion 22 of the port 12 . 
In such an embodiment , fluid flows from the reservoir 32 to 
the chamber 42 before flowing to the catheter 14 . By way of 
illustration , the first portion 22 of the port 12 may include a 
plurality of chambers 42 , for example and as illustrated in 
FIGS . 4 - 7 , four ( 4 ) chambers 42 ( i . e . , chambers 42a , 426 , 
42c , and 42d ) , each corresponding to one or more pods 16 
of the system 10 . It will be appreciated that while the 
illustrated embodiment includes four ( 4 ) chambers , in other 
embodiments , the port 12 may include more or fewer than 
four ( 4 ) chambers . Accordingly , the present disclosure is not 
limited to the port 12 including any particular number of 
chambers . In any event , because the port 12 in the embodi 
ment illustrated in FIGS . 4 - 7 includes four ( 4 ) chambers , the 
port 12 includes four ( 4 ) passageways 40 ( 40a , 406 , 40c , and 
40d shown in FIG . 7 , for example ) , each of which is 
configured to allow fluid in the reservoir 32 to flow into a 
respective chamber 42 . In an embodiment , the fluid pas 
sageways 40 either comprise or have disposed therein , 
one - way valves to allow fluid to flow from the reservoir 32 
to the chambers 42 , but to prevent the flow of fluid in the 
opposite direction . In such an embodiment , any suitable 
one - way valve may be used , as the present disclosure is not 
intended to be limited to any particular type ( s ) . 
[ 0027 ] Each chamber 42 may be defined or bounded by 
one or more interior walls of the first portion 22 , and may be 
coupled with one or more drains 44 in the port 12 to allow 
fluid to flow out from the chamber 42 . Accordingly , in an 
embodiment such as that illustrated in FIGS . 6 and 7 
wherein the port 12 includes four ( 4 ) chambers 42 ( i . e . , 
chambers 42a - 42d ) , there may be four ( 4 ) drains 44 ( i . e . , 
drains 44a - 44d ) . Each drain 44 may extend from the corre 
sponding chamber 42 to a connector member or element 46 
carried in or by the first portion 22 of the port 12 that is 
configured to mate with the end of the catheter 14 ( e . g . , a 
complementary connector member at the end of the catheter 
14 ) , and that allows fluid to flow from the port 12 to the 
catheter 14 . The drain ( s ) 44 may be arranged in such a 
manner that when the catheter 14 is coupled or connected to 
the port 12 , each drain 44 is aligned with a corresponding 
lumen of or in the catheter 14 . The connector member 46 
may comprise a male or female connector member , and may 
comprise any suitable connector known in the art that will 
facilitate the passage of fluid from the port 12 to the catheter 
14 . As such , the present disclosure is not limited to any 
particular type ( s ) of connector members or connection tech 
niques . 
[ 0028 ] With reference to FIGS . 5 and 8 , the second portion 
24 of the port body 20 is configured to house various 
electronics used in the control and operation of the system 
US 2018 / 0110919 A1 Apr . 26 , 2018 
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10 . In an embodiment , the port 12 also includes an electro 
mechanical connector 48 that is carried by the second 
portion 24 and that is comprised of one or more electrical 
contacts 50 to allow the port 12 , and the electronics stored 
therein , in particular , to be electrically connected to the 
pod ( s ) 16 . Any number of electrical components may be 
housed within the second portion 24 , including , but not 
limited to , one or more of an electronic control unit ( ECU ) 
52 , a power source 54 , a transmitter / receiver ( e . g . , a trans 
ceiver ) 56 , an ohm meter 58 , one or more switches or switch 
ar rays , and various conductors or wires to allow each the 
components to be connected to each other and / or to the 
electrical contacts 50 of the electromechanical port 48 . 
[ 0029 ] The ECU 52 may include any variety of electronic 
processing devices , memory devices , input / output ( I / O ) 
devices , and / or other known components , and may perform 
various functions relating to , for example , the operation and 
control of the system 10 . In an illustrative embodiment , the 
ECU 52 comprises an electronic memory device and an 
electronic processing device . The electronic memory device 
is configured to store various information , instructions , 
software , algorithms , data , threshold values , etc . to be used 
in the control and operation of the system 10 . The electronic 
processing device , which may comprise , for example , and 
without limitation , a microprocessor , a microcontroller , an 
application specific integrated circuit ( ASIC ) , etc . , is con 
figured to execute instructions for software , firmware , pro 
grams , algorithms , scripts , etc . that are stored in the memory 
device of the ECU 52 , and may at least partially govern 
some or all of the processes and methods described herein . 
[ 0030 ] The power source 54 may comprise one or more 
batteries or any other suitable power source known in the art , 
and may serve a number of purposes . For instance , it may 
provide operating power to other components housed within 
the second portion 24 of the port 12 , and / or to components 
or devices located in the pod ( s ) 16 of the system 10 . The 
power source 54 may also be used to facilitate impedance 
measurements of tissue proximate one or more of the pod ( s ) 
16 . Accordingly , the power source 54 may take any number 
of forms and may serve any number of purposes , including 
purposes not expressly described herein . 
[ 0031 ] The transmitter / receiver 56 may comprise a com 
bined transmitter / receiver ( i . e . , a transceiver ) , or may com 
prise a transmitter and a separate receiver . In either instance , 
the structure and function of the transmitter / receiver 56 is 
well known in the art , and as such , a detailed description will 
not be provided . To summarize , however , the transmitter / 
receiver 56 may comprise any suitable transmitter / receiver 
known in the art capable of receiving and transmitting 
electrical signals , for example , radio frequency ( RF ) signals . 
To that end , the transmitter / receiver 56 may include an 
antenna and other components required for receiving and 
transmitting electrical signals in the manner required for 
operating the system 10 . The transmitter / receiver 56 may be 
configured to facilitate wireless communications between 
the port 12 ( and the ECU 52 thereof , in particular ) and one 
or more other components of the system 10 , and / or between 
the port 12 and one or more other components or devices 
that are not part of the system 10 , but that are nonetheless 
used in conjunction with the system 10 . For example , the 
transmitter / receiver 56 may be configured to receive instruc 
tions , commands , and / or information from , and / or to send 
instructions , commands , and / or information to , an interro 
gator ( the interrogator 18 described below ) or another com 
ponents ( e . g . , base station ) located , for example , at a 
patient ' s bedside . In at least certain embodiments , the trans 
mitter / receiver 56 may be additionally or alternatively con 
figured to receive , for example , readings from wireless 
sensors ( e . g . , flow sensors ) located in the pod ( s ) 14 of the 
system 10 . In any event , in an embodiment , the transmitter / 
receiver 56 is electrically connected to the ECU 52 so as to 
allow for data and other information to be passed to and 
from the ECU 52 . Again , it will be appreciated that any 
suitable type of transmitter / receiver may be used , as the 
present disclosure is not limited to any particular type of 
transmitter / receiver . 
[ 0032 ] As is well - known in the art , the ohmmeter 58 is 
configured and operable to measure electrical resistance or 
impedance . As will be described in greater detail below , the 
ohmmeter 58 is configured to measure the electrical resis 
tance or impedance between two or more of the pods 16 , 
which , in an embodiment , comprises the resistance or 
impedance of tissue proximate two or more of the pods 16 . 
While in an embodiment the port 12 , and thus the system 10 , 
includes an ohmmeter that is separate and distinct from the 
ECU 52 , in other embodiments , the functionality of the 
ohmmeter 58 may be integrated within the functionality of 
the ECU 52 , and thus , the ECU 52 comprises the ohmmeter 
58 . Accordingly , it will be appreciated that any number of 
configurations or arrangements of the ohmmeter 58 may be 
utilized  
[ 0033 ] As briefly described above , in addition to the 
components described above , one or more switches 60 or 
arrays of switches 60 may also be housed in the second 
portion 24 of the port 12 . As will be described in greater 
detail below , some or all of these switches 60 may be used 
to electrically connect certain electronics or electrical com 
ponents in the port 12 with one or more components in the 
pods 16 . For example , a switch 60 may be configured to 
electrically connect the power source 54 to a fluid control 
valve located in a pod 16 . Another switch 60 may be 
configured to electrical connect the power source 54 to a 
needle actuation mechanism ( e . g . , electromagnet ( s ) , piezo 
electric element ( s ) , etc . ) located in a pod 16 . Switches may 
also be used to electrically connect electrodes ( e . g . , needles ) 
in the pods 16 to , for example , the ohmmeter 58 or ECU 52 , 
and / or sensors ( e . g . , flow sensors ) in the pods 16 to the ECU 
52 . In any event , operation of the switches 60 may be 
controlled by the ECU 52 such that the ECU 52 may 
command the opening and closing of the switches . Addi 
tionally , the switches 60 may comprise any suitable type of 
switch , for example , solid state switches and / or electrome 
chanical switches , the operation of which is / are well known 
in the art . Accordingly , it will be appreciated that any 
number of switches 60 may be provided to selectively 
connect various components of the port 12 and pods 16 
together , and that different types of suitable switches may be 
used . 
[ 0034 ] The electromechanical port 48 in or carried by the 
body 20 of the port 12 may comprise any suitable electro 
mechanical connector known in the art , and is configured to 
be mated with a complementary electromechanical connec 
tor of the catheter 14 . As shown in FIG . 8 , the electrome 
chanical connector 48 may comprise a female connector 
such that it is adapted to receive a complementary male 
connector of the catheter 14 , or may comprise a male 
connector configured to be inserted or plugged into a female 
connector of the catheter 14 . Accordingly , the present dis 
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closure is not limited to the use of any particular type of 
electromechanical connector , but rather any suitable con - 
nector may be used . 
[ 0035 ] As briefly described above , the system 10 includes 
one or more catheters 14 . In an embodiment wherein the 
system 10 includes a single pod 16 , the system 10 may 
include a single catheter 14 for coupling the port 12 with the 
pod 16 and for facilitating fluid communication and / or 
electrical connection ( s ) therebetween . However , in an 
embodiment wherein the system 10 includes a plurality of 
pods , a plurality of catheters 14 may be provided . For 
example , in the embodiment illustrated in FIG . 1 wherein 
the system 10 includes three ( 3 ) pods 16a - 16c , the system 
includes three ( 3 ) catheters 14 - catheter 14a coupling the port 
12 to the first pod 16a , catheter 14b coupling the first pod 
16a to the second pod 16b , and catheter 14c coupling the 
second pod 16b to the third pod 160 . Accordingly , the 
number of catheters 14 included in the system 10 may be 
dependent , at least in part , on the number of pods 16 
included in the system 10 . 
[ 0036 ] With reference to FIG . 9 , each catheter 14 has a 
shaft 62 having a first end and a second end opposite the first 
end , and that in an embodiment comprises a flexible shaft . 
The shaft 62 further includes one or more fluid lumens 64 
disposed therein extending between the first and second 
ends . As shown in FIG . 9 , the fluid lumens 64 may be 
integrally formed into the catheter shaft 62 , or alternatively 
may comprise one or tube ( s ) that are bundled within with the 
shaft 62 . In either instance , the number of fluid lumens 64 
that the catheter 14 includes may be dependent , at least in 
part , on the number of pods 16 in the system 10 , and / or the 
number of pods 16 downstream from that particular catheter 
14 . For example , in an embodiment such as that illustrated 
in FIG . 1 wherein the system 10 includes three ( 3 ) pods 16 , 
the shaft 62 of at least the catheter 14a that couples the port 
12 to the first pod 16a may include three ( 3 ) lumens 64 , each 
one feeding a respective one of pods 16a - 16c . In another 
embodiment , however , the shaft 62 may include a single 
fluid lumen 64 that feeds all three pods 16a - 16c . In such an 
embodiment , the catheter 14 may include orifices or outlets 
to which the pods 16a - 160 may be coupled and through 
which fluid flowing through the single lumen 64 may pass to 
the pods 16a - 16c . In other words , the catheter 14 may have 
a number of branches , each one of which is configured to be 
coupled to a respective pod 16 to supply fluid thereto . 
Accordingly , it will be appreciated that the number of 
lumens 64 that a shaft 62 of a given catheter 14 may have 
is not limited to any particular number , but rather different 
catheters 14 may have different numbers of lumens 64 . 
[ 0037 ] In addition to the fluid lumen ( s ) 64 , the shaft 62 of 
a catheter 14 may further include one or more passageways 
66 for housing electrical wires or conductors that extend 
from the first end of the catheter shaft 62 to the second end , 
and which may be used for electrically connecting electron 
ics or electrical components in the port 12 to various 
components in the pods 16 ( e . g . , valves , sensors , needle 
actuators , etc . ) . In other embodiments , the conductors / wires 
may be routed through the catheter ( s ) 14 in a manner other 
than through a passageway 66 , or even possibly through the 
fluid lumen ( s ) 64 . 
[ 0038 ] In any event , the fluid lumens 64 and electrical 
conductors extending through the shaft 62 of a catheter 14 
may each terminate at one or more connectors disposed at 
either end of the shaft 62 . These connectors are configured 
to couple or connect ( e . g . , fluidly , electrically , etc . ) the 
catheter 14 between or to the port 12 and a pod 16 , or 
between or to a pair of pods 16 to facilitate fluid and / or 
electrical communication / connections between the compo 
nents being coupled together . More particularly , each end of 
a given catheter 14 may include or carry a connector ( not 
shown ) that is configured to be mated with a complementary 
connector of either the port 12 or a pod 16 so as to allow 
fluid to flow from the port 12 or pod 16 to the catheter 14 , 
or from the catheter 14 to a pod 16 , as the case may be . Each 
end of the given catheter 14 may further include or carry an 
electromechanical connector 68 configured to be mated with 
a complementary electromechanical connector of either the 
port 12 ( e . g . , electromechanical connector 48 ) or a pod 16 to 
electrically connect the electronics or electrical components 
of the port 12 to the electrical conductors in the catheter 14 , 
or the electrical conductors in the catheter 14 to electrical 
conductors or components in the pod 16 to which the 
catheter 14 is being coupled . As shown in FIG . 9 , the 
electromechanical connector 68 on at least one end of one 
catheter 14 may comprise a male connector that includes a 
plurality of electrical contacts 70 ; though it will be appre 
ciated that a female connector configured to receive a 
complementary male connector may certainly be used 
instead . In any event , the connectors of the catheter 14 may 
comprise any suitable connectors known in the art , includ 
ing , for example , a single connector that facilitates both the 
electrical connection and fluid communication between the 
components the catheter 14 is coupling together , as opposed 
to two separate connectors on one end of the catheter 14 . As 
such , the present disclosure is not limited to any particular 
type ( s ) of connectors or connection techniques for the 
catheters 14 . 
[ 0039 ] As will be appreciated in view of the foregoing , the 
system 10 may include one pod 16 or a plurality of pods 16 
that may be linked or chained together ( see , for example , 
FIGS . 1 and 14 ) . In either instance , each pod 16 is config 
ured to be implanted in the body of a patient at a particular 
location at which the delivery of a particular fluid is needed 
or desired ( i . e . , at a desired injection site ) . In an embodi 
ment , the pod 16 may be held in place by suturing the pod 
16 to the organ or another anatomical structure to which 
fluid is being provided . As illustrated in , for example , FIGS . 
10a - 13 , each pod 16 comprises a housing 72 having a first 
end 74 and a second end 76 , and includes or defines an axis 
B . The housing 72 further includes a base 78 that , for reasons 
that will become apparent below , includes an axially extend 
ing aperture 80 disposed therein . It will be appreciated that 
unless otherwise noted , the description below of a pod 16 
applies with equal weight to each pod 16 of the system 10 . 
[ 0040 ] As best shown in FIG . 13 , the housing 72 of the 
pod 16 is configured to house various components of the pod 
16 , including , for example and without limitation , a deploy 
able needle assembly 82 , one or more fluid flow control 
valves 84 , one or more sensors 86 , and / or various electrical 
conductors ( e . g . , wires ) and / or fluid passageways , to cite a 
few possibilities . The housing 72 is also configured to carry 
one or more connectors of the pod 16 ( e . g . , one or more of 
the mechanical or electromechanical connectors described 
elsewhere above ) for coupling or connecting ( e . g . , fluidly , 
electrically , etc . ) the pod 16 to one or more catheters 14 to 
facilitate fluid and / or electrical communications or connec 
tions between the pod 16 and the port 12 , and / or between the 
pod 16 and one or more other pods 16 of the system 10 . In 
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other words , the connector ( s ) carried by the housing 72 of a 
given pod 16 may be mated with complementary connector 
( s ) of one or more catheters 14 in order to fluidly and / or 
electrically connect or couple the pod 16 to the port 12 
and / or one or more other pods 16 . For example , in the 
illustrative embodiments shown in FIGS . 10a - 13 , each pod 
16 includes a pair of electromechanical connectors 88 that , 
in this particular embodiment , comprise female connec 
torsone ( connector 88a ) configured to be mated with a 
complementary electromechanical connector 68 of a first 
catheter 14 , and the other connector 88b ) configured to be 
mated with a complementary electromechanical connector 
68 of a second catheter 14 . In any event , and as with the 
connectors of the catheter ( s ) 14 and port 12 described above , 
the connector ( s ) of the pod ( s ) 16 may comprise any suitable 
connectors known in the art as the present disclosure is not 
intended to be limited to any particular type ( s ) of connectors 
or connection techniques for the pod ( s ) 16 . 
[ 0041 ] Turning now to the components housed within the 
housing 72 , the needle assembly 82 generally comprises a 
needle 90 and an actuation mechanism 92 to move the 
needle 90 between retracted and deployed states . In at least 
some implementations , the needle assembly 82 may further 
include a guide or track 93 ( best shown in the illustrative 
embodiment depicted in FIGS . 12a and 12b ) to which the 
needle 90 may be secured / mounted to and supported by , and 
along which the needle 90 may travel when moving between 
the retracted and deployed states . In at least some embodi 
ments , when the needle assembly is in the retracted state , the 
entire needle assembly 82 is disposed within the housing 72 
of the pod 16 . Conversely , when in the deployed state , at 
least a portion of the needle 90 extends through the aperture 
80 in the housing 72 so as to engage and puncture the 
anatomical structure to which fluid is being delivered , 
thereby allowing fluid to be delivered to that structure . 
Accordingly , in an embodiment the needle 90 is arranged so 
as to be axially - aligned with the aperture 80 in the housing 
72 to allow the needled to extend through the aperture 80 
and into the anatomical structure . 
[ 0042 ] The needle 90 may serve a number of purposes . For 
one , it may provide a pathway for fluid to pass from the pod 
16 and into the anatomical structure to which fluid is being 
delivered . Accordingly , the needle 90 may be a hollow 
needle having a channel 94 therein through which fluid 
supplied to the needle 90 may pass . More particularly , and 
as will be described more fully below , the pod 12 may 
include one or more fluid passageways ( e . g . , tube ( s ) ) 95 that 
fluidly couple the needle 90 to a connector in the housing 72 
that , in turn , is coupled to a catheter 14 . The needle 90 may 
be coupled to a passageway ( e . g . , passageway 95a ) in a 
number of ways . For example , the end of the passageway 
95a may be sized and shaped to receive a portion of the 
needle 90 , which may be inserted into the passageway and 
held snuggly in place . In other embodiments , a collar 
overlying both a portion of the passageway 95a and a 
portion of the needle 90 may be used to couple and hold the 
passageway 95a and needle 90 together . Accordingly , it will 
be appreciated that any number of techniques may be used 
to couple the passageway and needle together , as the present 
disclosure is not intended to be limited to any particular 
technique ( s ) . In embodiment , one or more of the fluid 
passageway ( s ) 95 ( e . g . , passageway 95b in FIGS . 10a - 12b ) 
may be sufficiently flexible and / or extendable or expandable 
in an axial direction towards the needle 90 so as to allow the 
needle 90 to move between the retracted and deployed 
states . In any event , fluid from one or more fluid lumens 64 
in the catheter 14 may flow through the connector to the 
passageway ( s ) 95 in the pod 16 , and from the passageway ( s ) 
95 to the channel 94 in the needle 90 . As will be described 
below , a valve 84 may be used to control when fluid in the 
passageway ( s ) in the pods is ultimately allowed to flow to 
and / or through the channel 94 in the needle 90 , and thus , into 
the anatomical structure . 
[ 0043 ] The needle 90 of a given pod 16 may also serve a 
sensing function or purpose . As will be described in greater 
detail below , the needle 90 may act as a sensing electrode to 
measure or sense one or more electrical , electrophysiologi 
cal , or chemical parameters of interest , or parameter ( s ) that 
may be used to derive one or more parameter ( s ) of interest . 
For example , in an embodiment , the needle 90 may be used 
to measure or sense the electrical resistance or impedance in 
an area or region between two or more pods 16 ( e . g . , the 
impedance of a region of the anatomical structure to which 
fluid is being delivered ) , to cite just one example . To that 
end , at least a portion ( i . e . , the tip of the needle 90 may be 
electrically conductive , and may have one or more electrical 
conductors attached or affixed thereto extending from the 
needle 90 to an electromechanical connector 88 of the pod 
16 . When a catheter 14 is electrically connected between 
that pod 16 and the port 12 via that connector 88 , the needle 
90 is electrically connected to one or more electrical com 
ponents in the port 12 and one or more parameter ( s ) of 
interest may therefore be measured or sensed . 
[ 0044 ] The actuation mechanism 92 of the needle assem 
bly 82 is operable to cause the needle 90 to move between 
the retracted and deployed states and , in at least some 
embodiments , to control the flow of fluid through the needle 
90 . The actuation mechanism 92 may include a number of 
components and may be implemented in a number of ways . 
10045 ] One illustrative way is that illustrated in FIGS . 10a 
and 10b and involves the use of magnetic fields or forces to 
actuate the needle assembly 82 . More particularly , the 
actuation mechanism 92 includes one or more electromag 
nets ( e . g . , solenoids ) 96 disposed at or near the base 78 of 
the housing 72 . As is well known in the art , each electro 
magnet 96 may include a coil 97 formed of an electrical 
conductor ( e . g . , wire ) wound around a magnetic core or 
armature 98 that is movable relative to the coil . The needle 
90 is coupled to the armature ( s ) 98 of the electromagnet ( s ) 
96 such that the needle 90 moves as the armature ( s ) 98 
move . The electromagnet ( s ) 96 , and the coil ( s ) 97 thereof , in 
particular , may be electrically connected to a power supply , 
for example , the power supply 54 in the port 12 , via one or 
more switches and electrical conductors in the port 12 , the 
pod 16 ( e . g . , conductor ( s ) 99 , and the catheter ( s ) 14 con 
necting ( directly or indirectly ) the port 12 with the pod 16 . 
When the electromagnet ( s ) 96 is / are energized ( i . e . , current 
is applied ) , a magnetic field is generated that causes the 
armature ( s ) 98 , and therefore , the needle 90 coupled thereto , 
to be pulled in an axially - downward direction from the 
retracted state ( FIG . 10a ) to the deployed state ( FIG . 106 ) . 
The actuation mechanism 92 further includes one or more 
springs 100 to bias the needle 90 and to cause it to retract 
once the electromagnet ( s ) 96 is / are de - energized . In the 
embodiment illustrated in FIGS . 10a and 10b , the spring 100 
circumscribes the needle 90 ; though other suitable spring 
arrangements may certainly be used instead . In an embodi 
ment , the electromagnet ( s ) 96 may be selectively energized 
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using one or more of switches disposed between the coils 
and the power source 54 in the port 12 . The switch or 
switches may be disposed within the port 12 ( e . g . , one or 
more of the switches 60 in the port 12 ) and / or the housing 
72 of the pod 16 , and may be controlled by the ECU 52 
disposed in the port 12 . Accordingly , when it is determined 
that an injection of fluid is needed at the location of the 
anatomical structure that corresponds to a particular pod 16 , 
the ECU 52 causes the switch or switches corresponding to 
that pod 16 to close , thereby causing the electromagnet ( s ) 96 
to be energized and a magnetic field having a magnitude 
sufficient to overcome the bias of the spring 98 to be 
generated . As the needle 90 is pulled in an axially - downward 
direction toward the base of the housing 72 ( i . e . , towards the 
anatomical structure ) , the spring 100 compresses . When it is 
subsequently determined that the needle 90 is to be retracted , 
the ECU 52 may cause the appropriate switch ( es ) to open , 
thereby de - energizing the electromagnet ( s ) 96 . The de 
energizing of the electromagnet ( s ) 96 results in the removal 
of or reduction in the magnetic field such that the spring 100 
expands thereby causing the needle 90 to retract back to the 
retracted state . 
[ 0046 ] Another way in which the actuation mechanism 92 
may be implemented is that illustrated in FIGS . 11a and 11b 
and involves the use of piezoelectric elements to actuate the 
needle assembly 82 . More particularly , the actuation mecha 
nism 92 includes one or more piezoelectric elements 102 
carried within the housing 72 of the pod 16 that may be 
selectively electrically connected to , for example , the power 
supply 54 in the port 12 via one or more switches and 
electrical conductors in the port 12 , the pod 16 ( e . g . , 
conductor ( s ) 103 ) , and the catheter ( s ) 14 connecting ( di 
rectly or indirectly ) the port 12 with the pod 16 . As is known 
in the art , when electric current is supplied to the piezoelec 
tric element ( s ) 102 , the element ( s ) 102 deform ( s ) . This 
deformation causes the needle 90 coupled to the piezoelec 
tric element ( s ) 102 to be pushed in an axially - downward 
direction from the retracted state ( FIG . 11a ) to the deployed 
state ( FIG . 11b ) . When the current is subsequently removed , 
the piezoelectric element ( s ) 102 revert back to their original 
state and the needle 90 moves back to the retracted state . In 
an embodiment , current may be selectively applied to the 
piezoelectric element ( s ) 102 using one or more of switches 
disposed between the piezoelectric element ( s ) 102 and the 
power source 54 in the port 12 . The switch or switches may 
be disposed within the port 12 ( e . g . , one or more of the 
switches 60 in the port 12 ) and / or the housing 72 of the pod 
16 , and may be controlled by the ECU 52 disposed in the 
port 12 . Accordingly , when it is determined that an injection 
of fluid is needed at the location of the anatomical structure 
that corresponds to a particular pod 16 , the ECU 52 causes 
the switch or switches corresponding to that pod 16 to close , 
thereby causing current to be applied to the piezoelectric 
element ( s ) 102 . As the piezoelectric element ( s ) 102 deform , 
the needle 90 is pushed in an axially - downward direction 
toward base of the house 72 ( i . e . , towards the anatomical 
structure ) . When it is subsequently determined that the 
needle 90 is to be retracted , the ECU 52 may cause the 
appropriate switch ( es ) to open to remove the current from 
the piezoelectric element ( s ) 102 , thereby causing the piezo 
electric element ( s ) 102 to revert back to it / their original state 
and causing the needle 90 to retract back to the retracted 
state . 
[ 0047 ] Yet another way in which the actuation mechanism 
92 may be implemented is that illustrated in FIGS . 12a and 
12b and involves the use of pressure to actuate the needle 
assembly 82 , and thus may be considered to be a hydraulic 
actuation mechanism . More particularly , as fluid is supplied 
to the pod 16 and flows to the channel 94 of the needle 90 , 
the pressure of the fluid may cause the needle 90 to be 
pushed in an axially - downward direction from the retracted 
state ( FIG . 12a ) to the deployed state ( FIG . 12b ) along the 
track 93 , which , in this embodiment , may comprise one or 
more hydraulic rams . The pressure that causes the needle 
assembly 82 to actuate may be that of the fluid itself ( e . g . , 
when a certain amount of fluid has flowed to the needle 90 , 
the pressure applied to the needle assembly by the fluid 
causes the needle 90 to move downwardly ) , may be the 
pressure applied to the fluid by a physician / clinician who is 
infusing the port 12 with the fluid ( e . g . , the pressure applied 
via the plunger of a syringe used to infuse the port 12 ) , or 
a combination of both . Once the needle 90 has been 
deployed and the desired amount of fluid has been injected 
into the anatomical structure , the pressure lessens and the 
needle 90 moves back to the retracted state . In an embodi 
ment , the hydraulic rams may include one or more springs 
or other resilient elements to facilitate the movement of the 
needle 90 back to the retracted state , much like the spring 
100 in the embodiment illustrated in FIGS . 10a and 10b . In 
any event , in the illustrative implementation , the actuation 
mechanism 92 comprises the needle 90 and the track 93 of 
the needle assembly 82 . 
[ 0048 ] While certain particular ways in which the needle 
actuation mechanism 92 may be implemented have been 
described above , it will be appreciated that any suitable 
implementation may be used as the needle actuation mecha 
nism 92 is not limited to any particular implementation ( s ) . 
[ 0049 ] As mentioned above and shown in FIGS . 10a - 14 , 
in at least some embodiments the pod 16 includes one or 
more valves 84 and / or one or more sensors 86 . The valve ( s ) 
84 and / or sensor ( s ) 86 are housed within the housing 72 and 
may be used in the control and / or monitoring of fluid 
flowing through the pod 16 . The valve ( s ) 84 and / or sensor ( s ) 
may comprise constituent components , for example , the 
needle assembly 82 ( and the actuation mechanism 92 
thereof , in particular ) or may be separate and distinct from 
other components of the pod 16 . In either instance , the 
valve ( s ) 84 and / or sensor ( s ) 86 may be necessary in embodi 
ments wherein the needle 90 may be deployed without 
delivering fluid to the anatomical structure . For example , in 
an embodiment wherein the needle 90 serves a sensing 
function , it may be desirable for the needle to be deployed 
and to puncture the anatomical structure , but it may not be 
desirable for the needle 90 to also deliver fluid to the 
structure while the sensing function is being performed . 
Such components may also be necessary in embodiments 
wherein a particular amount of fluid ( dosage ) is being 
delivered to the anatomical structure . For example , it may be 
desirable to stop the delivery of fluid once a particular 
amount has been delivered . 
[ 0050 ] To that end , and with reference to FIG . 13 , for 
example , a valve 84 may be disposed anywhere in the fluid 
path between the catheter 14 that supplies fluid to the pod 16 
and the needle 90 . In an embodiment , such as , for example , 
that illustrated in FIG . 13 ( and those illustrated FIGS . 
10a - 12b ) , the valve 84 may be coupled between two fluid 
passageways 95 ( i . e . , 95a and 95b ) in the pod 16 and 
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configured to selectively allow fluid to flow therebetween . 
The valve 84 may be an electrically controlled valve that 
may be selectively coupled to , for example , the power 
source 54 of the port 12 by one or more switches ( e . g . , one 
or more switches 60 disposed in the port 12 ) , which , in turn , 
may be selectively controlled by the ECU 52 housed in the 
port 12 . Accordingly , in an embodiment , the valve 84 may 
be coupled to electrical components in the port 12 through 
one or more electrical conductors of one or more catheter ( s ) 
14 that connect , directly or indirectly , the port 12 to the pod 
16 , and one or more electrical conductors 104 in the pod 16 
that electrically connect the valve 84 to the conductor ( s ) of 
the one or more catheters 14 ( e . g . , electrical conductor ( s ) 
extending from the valve 84 to an electromechanical con 
nector 88 of the pod 16 that is configured to be electrically 
connected to electrical conductor ( s ) of a catheter 14 that , in 
turn , is connected to the port 12 ) . The valve 84 may 
comprise any suitable valve known in the art that is config 
ured for use in controlling the flow of fluid as the present 
disclosure is not intended to be limited to any particular type 
of valve . 
10051 ] . Like the valve 84 , the flow sensor 86 may also be 
disposed anywhere in the fluid path between the catheter 14 
that supplies fluid to the pod 16 and the needle 90 , and may 
preferably be disposed between the valve 84 in the pod 16 
and the needle 90 . Readings from the sensor 86 may be 
communicated back to the electronics in the port 12 ( e . g . , 
ECU 52 ) and used for a variety of purposes , including , but 
not limited to , those described herein . Depending on the 
implementation , the readings may be communicated wire 
lessly or over one or more electrical conductors . In the latter 
instance , the sensor 86 may be coupled to the appropriate 
electronics in the port 12 through , for example , one or more 
electrical conductors of one or more catheter ( s ) 14 that 
connect , directly or indirectly , the port 12 to the pod 16 , and 
one or more electrical conductors 105 in the pod 16 that 
electrically connect the sensor 86 to the conductor ( s ) of the 
one or more catheters 14 ( e . g . , one or more electrical 
conductors extending from the sensor 86 to an electrome 
chanical connector 88 of the pod that is configured to be 
connected to electrical conductors of a catheter 14 that , in 
turn , is connected to the port 12 ) . Readings from the sensors 
may be used to determine that fluid is , in fact , flowing to the 
pod and / or through the needle 90 thereof , and / or to deter 
mine how much fluid has flowed therethrough . As will be 
described below , these readings may then be used in the 
control the valve ( s ) 84 in the pod 16 . For example , the ECU 
52 in the port 12 may be configured to use readings from the 
sensor 86 to monitor the amount of fluid that has been 
delivered to the anatomical structure by that pod 16 . When 
the sensed amount of fluid reaches a predetermined thresh 
old programmed into the memory of the ECU 52 , the ECU 
52 may cause the valve ( s ) 84 of that pod 16 to close , thereby 
preventing the further delivery of fluid to the anatomical 
structure . In another embodiment , readings from the sensor 
86 may be used to determine when to deploy the needle 90 . 
More particularly , upon the receipt of readings from the flow 
sensor 86 indicative of fluid reaching the pod 12 / needle 90 , 
the ECU 52 may cause the needle 90 to be deployed so that 
the fluid can then be delivered to the anatomical structure . 
These are , of course , only a few examples of how readings 
from a flow sensor 86 may be used , and it will be appreciated 
that flow sensor readings may be used for any number of 
additional or alternate reasons or purposes . It will be further 
appreciated that the pod 16 may include one or more flow 
sensors 86 to monitor the flow of fluid through different 
areas of the pod 16 , and that the sensor ( s ) 86 may comprise 
any suitable flow sensor known in the art that is configured 
to measure or sense the fluid flow . 
[ 0052 ] In addition to the fluid passageways / pathways and 
electrical conductors already described above , in certain 
embodiments or implementations , a given pod 16 may 
include any number of additional fluid pathways and / or 
electrical conductors . More particularly , in an instance 
wherein the system 10 includes two or more pods 16 , one or 
more of the pods 16 may include one or more fluid pathways 
106 and / or one or more electrical conductors 108 extending 
therethrough to allow downstream pod ( s ) 16 to be opera 
tively coupled or connected to the port 12 so as to facilitate 
fluid communication and / or electrical connections between 
the downstream pod ( s ) 16 and the port 12 . In such an 
embodiment , these " additional ” fluid pathway ( s ) 106 and / or 
electrical conductors 108 may extend between connectors 
( e . g . , mechanical and / or electromechanical connectors ) in 
the housing 72 that are configured to be coupled or con 
nected to respective catheters 14 , thereby bypassing any of 
the other components of the pod 16 described above ( e . g . , 
the needle assembly 82 ) . 
10053 ] To better illustrate , FIG . 14 illustrates an embodi 
ment of the system 10 wherein the system includes four ( 4 ) 
pods 16 ( i . e . , 16a - 16d ) . In this embodiment , the pod 16a 
( which is also illustrated in FIG . 13 ) is connected or coupled 
to the port 12 via the catheter 14a and to the pod 16b via the 
catheter 14b . The pod 16a includes the fluid pathway 95 that 
allows fluid from a lumen 64 in the catheter 14a to be 
communicated to the needle assembly 82 of the pod 16a . 
Because there are three ( 3 ) pods downstream of the pod 16a , 
the pod 16a also includes three ( 3 ) additional fluid pathways 
106a - 106c , each one corresponding to a respective one of 
the downstream pods 166 - 16d . Accordingly , each of the 
pathways 106a - 106c extend from the connector of the pod 
16a that is mated with the catheter 14a , to the connector of 
the pod 16a that is mated with the catheter 14b . The 
connector coupling the pod 16a with the catheter 14b is 
configured to allow fluid to flow from the pathways 106a 
106c in the pod 16a to one or more fluid lumens 64 in the 
catheter 14b . In at least some embodiments , the pod 16a may 
also include electrical conductors to electrically connect 
electrical conductors in the catheter 14a ( and therefore , 
electrical components of the port 12 ) to one or more com 
ponents in the pod 16a ( e . g . , the valve 84 , the sensor 86 , 
etc . ) . The pod 16a would also include electrical conductors 
108 to allow each of the downstream pods 16b - 16d to be 
electrically connected to the port 12 . Accordingly , the pod 
16a may include electrical conductors 108 that extend from 
the electromechanical connector 88a of the pod 16a that is 
mated with the catheter 14a ( and a connector 68 thereof , in 
particular ) to the electromechanical connector 88b of the 
pod 16a that is mated with the catheter 14b ( and a connector 
68 thereof , in particular ) . The connector 88b is configured to 
electrically connect the relevant conductors 108 in the pod 
16a to electrical conductor ( s ) in the catheter 14b which , as 
shown in FIG . 14 , couples pods 16a and 16b together . 
[ 0054 ] As shown in FIG . 14 , the pod 16b is connected or 
coupled to the pod 16a via the catheter 14b , and to the pod 
160 via the catheter 14c . As with the pod 16a , the pod 16b 
includes the fluid pathway 95 that allows fluid from a lumen 
64 in the catheter 14b ( that passed through the pod 16a ) to 
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be communicated to the needle assembly 82 of the pod 16b . 
Because there are two ( 2 ) pods downstream of the pod 16b , 
the pod 16b also includes two ( 2 ) additional fluid pathways 
106b and 106c , each one corresponding to a respective one 
of the downstream pods 16c and 16d . Accordingly , each of 
the pathways 106b , 106c extend from the connector of the 
pod 16b that is mated with the catheter 14b , to the connector 
of the pod 16b that is mated with the catheter 14c . The 
connector coupling the pod 16b with the catheter 14c is 
configured to allow fluid to flow from the pathways 106b , 
106c in the pod 16b to one or more fluid lumens 64 in the 
catheter 14c . In at least some embodiments , the pod 16b 
would also include electrical conductors to electrically con 
nect electrical conductors in the catheter 14b ( and indirectly 
the electronics in the port 12 ) to one or more components in 
the pod 16b ( e . g . , the valve 84 , the sensor 86 , etc . ) . The pod 
16b would also include electrical conductors 108 to allow 
each of the downstream pods 16c and 16d to be electrically 
connected to the port 12 . Accordingly , the pod 16b may 
include electrical conductors 108 that extend from the 
electromechanical connector 88a of the pod 16b that is 
mated with the catheter 14b ( and a connector 68 thereof , in 
particular ) to the electromechanical connector 88b of the 
pod 16b that is mated with the catheter 140 ( and a connector 
68 thereof , in particular ) . The connector 88b of the pod 16b 
is configured to electrically connect the relevant conductors 
in the pod 16b to electrical conductor ( s ) in the catheter 14c , 
which , as shown in FIG . 14 , couples pods 16 and 160 
together 
[ 0055 ] As shown in FIG . 11 , pods 16c and 16d would be 
arranged or configured in a substantially similar manner as 
that described above with respect to pods 16a and 16b , and 
therefore , a detailed description of those pods will not be 
provided 
10056 ] In addition to the components described above , in 
at least some embodiments or implementations such as that 
illustrated in FIG . 1 , the system 10 may further include the 
interrogator or base station 18 briefly described above . The 
interrogator 18 is configured for wireless communication 
with the electronics in the port 12 , and the ECU 52 thereof , 
in particular . More specifically , electrical signals may be 
passed between the interrogator 18 and the ECU 52 through 
the transmitter / receiver 56 housed in the port 12 and elec 
trically connected to the ECU 52 . This communication may 
be over any number of known communication networks or 
links using any number of known communication protocols 
( e . g . , personal area networks ( PAN ) , wireless local area 
network ( WLAN ) , IEEE 802 . 11 , Wi - Fi , WiMax , etc . ) . 
[ 0057 ] The interrogator 18 may be utilized by a user ( e . g . , 
physician or clinician ) for a number of purposes . For 
example , the user may use the interrogator 18 to command 
the delivery of fluid by one or more of the pods 16 of the 
system 10 . The user may use the interrogator 18 to set or 
adjust certain operating parameters of the system 10 ( e . g . , 
the threshold ( s ) corresponding to the maximum amount of 
fluid that is to be delivered 16 to a particular location by a 
particular pod 16 ) . The interrogator 18 may display the 
values of one or more parameters ( e . g . , electrophysiological 
parameter ( s ) ) that are measured or sensed by the electronics 
in the port 12 and communicated to the interrogator 18 in 
order to allow the user to evaluate the efficacy or of the 
treatment being performed via the fluid delivery , and / or to 
determine whether adjustments to that treatment are required 
( e . g . , more fluid is required ) . The user may also use the 
interrogator 18 to monitor the operation of the pod ( s ) in the 
system to ensure that all of the pod ( s ) 16 are operating in an 
expected manner . 
[ 0058 ] . The interrogator 18 may comprise any number of 
suitable devices known in the art , and therefore , a detailed 
description of the structure and operation of the interrogator 
18 will not be provided . To summarize , however , the inter 
rogator 18 may include a combination of hardware , soft 
ware , and / or other components that enable the communica 
tion or exchange of information between a user and the 
system 10 , and the electronics in the port 12 thereof , in 
particular . For example , the interrogator may include an 
electronic processing device ( e . g . , a microprocessor , micro 
controller , ASIC , etc . ) , an electronic memory device , and an 
antenna . The interrogator 18 may further include one or 
more user interfaces to allow the user to receive information 
from and / or provide information to , the system 10 . The 
interface ( s ) may include , for example , and without limita 
tion , a liquid crystal display ( LCD ) , a touch screen LCD , a 
keypad , a keyboard , a microphone , and / or a speaker , to cite 
a few possibilities . Again , the present disclosure is not 
intended to be limited to any particular type of interrogator 
or other like device , but rather any suitable device may be 
used . 
[ 0059 ] As at least briefly described above , the system 10 
may be configured to perform one or more functions . One 
obvious function is the delivery of fluid to one or more 
regions or areas of one or more anatomical structures . For 
purposes of illustration , one particular way of performing 
this function will be described below with respect to the 
embodiment of the system illustrated in FIG . 14 ; it will be 
appreciated , however , that other ways may certainly be used 
in addition to or in lieu of that described below using 
different embodiments of the system 10 . 
[ 0060 ] First , the port 12 , catheter ( s ) 14 ( i . e . , 14a - 14d ) , and 
pods 16 ( 16a - 16d ) are implanted into the body of the patient . 
Next , the port 12 is infused with the fluid to be delivered to 
the pods 16 and ultimately injected into the anatomical 
structure ( s ) to which the pods 16 are affixed . In an embodi 
ment , this may comprise locating the septum or diaphragm 
34 of the port 12 and inserting the needle of a syringe 
through the septum 34 and into the reservoir 32 of the port . 
The fluid in the syringe may then be injected into the 
reservoir 32 by pushing down on a plunger of the syringe . 
As the fluid fills the reservoir , the pressure applied to the 
plunger of the syringe causes the fluid to flow equally into 
the chambers 42a - 42d of the port 12 , through the drains 
44a - 44d and into respective fluid lumens 64 in the catheter 
14a , and ultimately into the pods 16a - 16d . 
[ 0061 ] Once the system 10 is loaded with the fluid to be 
delivered , one or more needle assemblies 82 in the pods 
160 - 16d are actuated to deliver the fluid to the anatomical 
structure . In an embodiment , this comprises the ECU 52 in 
the port 12 determining which of the needle assemblies 82 
to actuate , and then causing that or those assemblies to 
actuate . This determination may be made automatically by 
the ECU 52 , or alternatively may be made in response to a 
command or input received from the interrogator 18 . For 
purposes of illustration only , assume that it is determined 
that only the needle assembly 82 of the pod 16a is to be 
actuated . In response to this determination , the ECU 52 may 
control one or more switches 60 in the port 12 to couple one 
or more components in the pod 16a to the power source 54 
in the port 12 to actuate the assembly 82 . Depending on the 
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particular implementation , this may comprise , for example , 
controlling one or more switches 60 to cause the needle 
assembly 82 to move to the deployed state . This may 
additionally or alternatively comprise controlling one or 
more switches 60 to electrically connect the valve 84 in the 
pod 16a to the power source 54 , thereby opening the valve 
54 to allow fluid to flow through the channel 94 in the needle 
90 . 
[ 0062 ] In an embodiment , as the fluid flows through the 
pod 16a to the needle 90 , readings from the flow sensor 86 
may be communicated back to the ECU 52 through con 
ductors and or other components ( e . g . , switches ) in the pod 
16a , catheter 14a , and port 12 . When it is determined by the 
ECU 52 that a particular amount of fluid has been delivered 
through the needle 90 to the anatomical structure ( by , for 
example , comparing the readings received from the flow 
sensor 86 to a predetermined threshold value ) , the ECU 52 
may cause the flow of fluid to be stopped and / or the needle 
90 to be retracted . This may comprise , for example , con 
trolling the one or more switches 60 that electrically connect 
( s ) one or more components in the pod 16a to the power 
source 54 to disconnect that or those components from the 
power source 54 , thereby causing the needle assembly 82 to 
move to the retracted state . This may additionally or alter 
natively comprise controlling the one or more switches 60 
that electrically connect the valve 84 in the pod 16a to the 
power source 54 to disconnect the valve 84 from the power 
source 54 , thereby closing the valve 84 to prevent ( or at least 
limit ) additional fluid from flowing through the needle 90 . 
[ 0063 ] In an embodiment , once the desired amount of fluid 
has been delivered to the anatomical structure , the system 10 
( e . g . , port 12 , catheter ( s ) 14 , and pod ( s ) 16 ) may be flushed 
and / or primed with saline or another suitable fluid . This may 
comprise , for example , infusing the port 12 with saline in the 
same or similar manner as that described immediately 
above , and then actuating one or more of the needle assem 
blies 82 of the pods 16a - 16d to flush and / or prime the system 
10 . 
[ 0064 ] While one particular way of operating the system 
10 to deliver fluid to an anatomical structure has been 
described above , it will be appreciated that the present 
disclosure is not intended to be limited solely to this par 
ticular way . Rather , the system 10 may be operated in any 
number of other suitable ways , each of which remains within 
the spirit and scope of the present disclosure . It will be 
further appreciated that while the description above was 
primarily with respect to pod 16a , the description also 
applies to the other pods 166 - 16d with equal force . 
[ 0065 ] As briefly described above , another function that 
the system 10 may perform relates to the sensing or mea 
suring of one or more parameter ( s ) of interest , or one or 
more parameter ( s ) that may be used to derive one or more 
parameter ( s ) of interest . For purposes of illustration only , the 
description below will be with respect to the sensing or 
measuring of electrical resistance or impedance , and , in an 
embodiment , the resistance or impedance of an anatomical 
structure ( e . g . , tissue or muscle ) or particular region thereof 
( i . e . , between two pods ) , in particular . It will be appreciated , 
however , that the present disclosure is not intended to be 
limited solely to the sensing or measuring of impedance ; 
rather any number of parameter ( s ) may be sensed or mea 
sured by the system 10 . 
10066 ] . In any event , in an instance wherein the system 10 
is configured to sense or measure impedance , the system 10 
may be configured to do so in a number of ways . One such 
way is that illustrated in FIG . 15 . In this embodiment , the 
needle 90 of one of the pods 16 ( e . g . , pod 16a in FIG . 15 ) 
is electrically connected to the power source 54 in the port 
12 to allow current to flow into the anatomical structure 
( reference numeral 110 in FIG . 15 ) when the needle 90 is 
deployed and penetrates the anatomical structure . The elec 
trical connection between the needle 90 and the power 
source 54 may be through one or more switches 60 in the 
port that may be controlled by the ECU 52 . The current that 
flows into the anatomical structure from the needle 90 of the 
pod 16a flows through the needle ( s ) 90 of one or more other 
pods 16 ( e . g . , pod 16b in FIG . 15 ) when that or those needles 
90 are deployed and penetrate ( s ) the anatomical structure . 
The current then flows back to one or more components in 
the port 12 ( e . g . , the ohmmeter 58 or ECU 52 ) that the 
needle ( s ) 90 are electrically connected to where it is used to 
measure or calculate the impedance of at least a portion of 
the anatomical structure extending between the two needles 
90 . The electrical connection between the needle 90 of the 
pod 16b and the electronics of in the port 12 may be 
facilitated through one or more switches 60 in the port 12 
that may be controlled by the ECU 52 . The current path 
described above is represented in FIG . 15 by arrows . 
[ 0067 ] In embodiment , only the needle 90 of one pod 16 
( e . g . , pod 16a ) may be selectively electrically connected to 
the power source 54 as described above , and only the needle 
90 of another pod 16 ( e . g . , pod 16b ) may be selective 
electrically connected to the component ( s ) of the port 12 that 
measure / calculate the impedance . In other embodiments , 
however , the needles 90 of multiple pods 16 may be con 
figured to be individually selectively electrically connected 
to the power source 54 , components of the port 12 for 
measuring / calculating impedance , or both . In the latter 
instance , impedance measurements of different regions of 
the anatomical structure may be made using different pod 
combinations to make the necessary measurements . In any 
event , the electrical connections between the power source 
54 or other components in the port 12 and the needles 90 of 
one or more pods 16 may be facilitated by one or more 
switches 60 that may be controlled by the ECU 52 to couple 
the power source 54 and / or impedance measuring / calculat 
ing components to the appropriate needles 90 , and electrical 
conductors disposed within the pods 16 , catheter ( s ) 14 , and 
the port 12 . 
[ 0068 ] Impedance measurements may be used for a vari 
ety of purposes . These measurements may be used by a 
physician or clinician to evaluate the anatomical structure 
being treated in order to determine if and / or how much fluid 
should be delivered to the structure or a particular region 
thereof . By way of illustration , in an embodiment wherein 
botox is the fluid being delivered to one or more particular 
regions of an anatomical structure , the resistance or imped 
ance of that or those regions may be measured in the manner 
described above and used to determine or evaluate the 
relaxation or paralysis / blockage state of the region , which , 
in turn , may then dictate whether or not and / or how much 
botox should be delivered . Accordingly , the impedance of 
one or more regions of the anatomical structure may be 
measured and the measured value may then be used by the 
ECU 52 to automatically make the necessary determinations 
as to if botox should be delivered , and if so , how much ( e . g . , 
by looking up the measured value in a look - up table or other 
data structure that correlates impedance with empirically 
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derived botox dosages and / or indications of whether botox 
delivery is needed ) , or the value ( s ) may be communicated 
to , and displayed , at the interrogator 18 for a physician or 
clinician to view and then , if appropriate , provide commands 
to the ECU 52 to cause botox to be delivered to one or more 
regions using one or more pods 16 . 
[ 0069 ] Impedance measurements may additionally or 
alternatively be used to evaluate the operation of the pods 
16 , and more particularly , to evaluate whether the needle 
assemblies 82 thereof are operating ( e . g . , deploying ) prop 
erly or in expected manner . For example , impedance may be 
measured in the manner described above and the measured 
value may be evaluated to determine whether or not the 
needle assemblies 82 of one or more of the pods 16 have 
deployed properly . More particularly , if an impedance mea 
surement is made that exceeds ( or , in an embodiment , meets 
or exceeds ) a predetermined threshold or is outside of a 
predefined range ( i . e . , is too high to be the impedance of an 
anatomical structure ) , then it may be determined that one or 
more of the needles 90 of the needle assemblies 82 of two 
or more pods 16 is not in contact with the anatomical 
structure but rather is in " air , ” and thus , did not deploy 
properly . Measures may then be taken to address the func 
tionality and operation of that or those particular pod ( s ) 16 . 
[ 0070 ] Accordingly , it will be appreciated that impedance 
measurements made by the system 10 may be used for a 
variety of purposes , including , but not limited to , those 
described above . 
[ 0071 ] It is to be understood that the foregoing is a 
description of one or more embodiments of the invention . 
The invention is not limited to the particular embodiment ( s ) 
disclosed herein , but rather is defined solely by the claims 
below . Furthermore , the statements contained in the forego 
ing description relate to particular embodiments and are not 
to be construed as limitations on the scope of the invention 
or on the definition of terms used in the claims , except where 
a term or phrase is expressly defined above . Various other 
embodiments and various changes and modifications to the 
disclosed embodiment ( s ) will become apparent to those 
skilled in the art . All such other embodiments , changes , and 
modifications are intended to come within the scope of the 
appended claims . 
[ 0072 ] As used in this specification and claims , the terms 
" e . g . , " " for example , " " for instance , " " such as , ” and “ like , " 
and the verbs “ comprising , ” “ having , ” “ including , " and their 
other verb forms , when used in conjunction with a listing of 
one or more components or other items , are each to be 
construed as open - ended , meaning that the listing is not to 
be considered as excluding other , additional components or 
items . Other terms are to be construed using their broadest 
reasonable meaning unless they are used in a context that 
requires a different interpretation . 
1 . A port adapted for use in an implantable fluid delivery 
system , comprising : 
a body including an opening at one end thereof , and 
having disposed therein : 
a fluid reservoir ; 
a plurality of chambers ; 
a plurality of fluid passageways each configured to fluidly 
couple the fluid reservoir with a respective one of the 
plurality of chambers ; and 
a plurality of drains each of which is in fluid communi 
cation with a respective one of the plurality of cham 
bers ; 
a septum carried by the body and extending across and 
overlaying the opening of the body , the septum being 
penetrable by a needle to inject fluid into the fluid 
reservoir ; and 
a connector carried by the body and fluidly coupled to the 
plurality of chambers by the plurality of drains , 
wherein the connector is configured to be mated with a 
complementary connector of another component of the 
fluid delivery system to at least fluidly couple the port 
to the other component . 
2 . The port of claim 1 , wherein each of the plurality of 
fluid passageways comprises a one - way valve configured to 
allow fluid in the reservoir to flow to corresponding cham 
ber , and to prevent fluid in the chamber from flowing into the 
reservoir . 
3 . An implantable pod adapted for use in an implantable 
fluid delivery system , comprising : a housing including a 
base having an aperture therein ; 
a needle assembly disposed within the housing and com 
prising 
a hollow needle having a channel therein configured to 
allow fluid supplied to the needle assembly to flow 
therethrough , and 
a needle actuation mechanism configured to move the 
needle between a retracted state and a deployed state , 
wherein when in the deployed state , at least a portion 
of the needle extends through the aperture in the base 
of the housing ; 
a connector carried by the housing and configured to be 
mated with a complementary connector of another 
component of the fluid delivery system to at least 
fluidly couple the pod to the other component ; and 
one or more fluid passageways disposed within the hous 
ing to fluidly couple the connector to the needle assem 
bly . 
4 . A fluid delivery system for delivering fluid to an 
anatomical structure of a patient , comprising : 
a port having a fluid reservoir and a connector in fluid 
communication with the fluid reservoir ; 
an implantable pod having a needle assembly comprising 
a hollow needle , and 
a needle actuation mechanism configured to move the 
needle between a retracted state and a deployed state , 
and a connector in fluid communication with the needle 
assembly ; and a catheter configured comprising 
a shaft having a first end , a second end opposite the first 
end , and at least one fluid lumen disposed therein 
extending between the first and second ends , 
a first connector disposed at the first end of the shaft , and 
a second connector disposed at the second end of the 
shaft , 
wherein one of the first and second connectors is config 
ured to be mated with the connector of the port , and the 
other of the first and second connectors is configured to 
be mated with the connector of the pod so as to at least 
fluidly couple the port to the pod . 
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